|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/46 | (2006.01) |
| C07K 14/705 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| C12N 9/16 | (2006.01) |
| (11) | Number of the document | 3180363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15750744.3 |
| Date of filing the European patent application | 2015-08-14 | |
| (97) | Date of publication of the European application | 2017-06-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-25 |
| (46) | Date of publication of the claims translation | 2019-11-25 |
| (86) | Number | PCT/EP2015/068798 |
| Date | 2015-08-14 |
| (87) | Number | WO 2016/024021 |
| Date | 2016-02-18 |
| (30) | Number | Date | Country code |
| 201462038196 P | 2014-08-15 | US |
| (72) |
LO, Kin-Ming, US
ZIZLSPERGER, Nora, US
SIRCAR, Aroop, US
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | SIRP-alfa imunoglobulino sulieti baltymai |
| SIRP-ALPHA IMMUNOGLOBULIN FUSION PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2021-07-22 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-08-14 |